BUSINESS GROUPS
Sustainable Growth, Faster Innovation, and a Profitable Future
Kollestee UK Global
In May 2023, in the United Kingdom, a new organisational structure was introduced by Kollestee UK Global to help its global businesses navigate to sustainable growth, faster innovation, and a profitable future. The structure was created so that decisions would be clarified, delivery would be accelerated, and investment would be focused where it matters most.
Our nine Business Groups
Kollestee UK Global is now operated through nine Business Groups. Together, they are recognised as the Pioneer Organisations, each being assigned a sharp mandate and a clear outcome.
These groups have been established to deliver Kollestee UK Global’s Pioneer Strategies and to guide Purpose-Led, Future-Fit companies toward Global Leadership in Sustainable, Reliable, and Repeatable businesses.

Focus: A defined mission is owned by each group, so accountability is clarified and progress is made visible.
Speed: Handoffs are simplified and decision cycles are shortened, so movement from lab to market is accelerated.
Reliability: Standards, governance, and evidence requirements are embedded, so outcomes are made repeatable and trusted.
Investor readiness: Milestone-based roadmaps are used, so capital can be deployed with confidence.
Kollestee UK Global's Business Groups
Innovation Focused Groups!
Organisational Flow

BUSINESS GROUPS
From curiosity to certainty
Original research is pursued across priority scientific fields, and validated data are generated to unlock new possibilities. Collaboration is established with universities, institutes, and industry partners, so that findings are rigorous, reproducible, and ready for transfer. Insight is positioned as the launchpad for technology and market impact.
Engineering tomorrow’s tools today
Fresh knowledge is translated into robust platforms, devices, and software. Every build is specified by real market needs, stress tested for reliability, and designed for scalable manufacturing. Intellectual property is created that shortens development timelines and lowers risk for downstream innovators.
Better care through validated innovation
Medical technologies that improve outcomes and efficiency are developed and introduced to the market. Alignment is maintained with UK and global regulatory requirements, clinical evidence, and healthcare economics, so that adoption is achieved safely and sustainably across systems and markets.
Capital that understands innovation
Financing that matches the journey from lab to market is structured. Instruments are provided for research, technology development, and commercial rollout, with diligence undertaken on IP strength, traction, and risk mitigation. Transparent terms and aligned incentives are offered to partners.